Cargando…

Role of abnormal energy metabolism in the progression of chronic kidney disease and drug intervention

Chronic kidney disease (CKD) is a severe clinical syndrome with significant socioeconomic impact worldwide. Orderly energy metabolism is essential for normal kidney function and energy metabolism disorders are increasingly recognized as an important player in CKD. Energy metabolism disorders are cha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Xuyan, Du, Huasheng, Sun, Yan, Shao, Leping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2022
Materias:	State-of-the-Art Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103584/ https://www.ncbi.nlm.nih.gov/pubmed/35535500 http://dx.doi.org/10.1080/0886022X.2022.2072743

Ejemplares similares

Cardiovascular Disease in Chronic Kidney Disease: Pathophysiological Insights and Therapeutic Options
por: Jankowski, Joachim, et al.
Publicado: (2021)

Research progress on related mechanisms of uric acid activating NLRP3 inflammasome in chronic kidney disease
por: Wang, Miao, et al.
Publicado: (2022)

Advance of autophagy in chronic kidney diseases
por: Deng, Xu, et al.
Publicado: (2017)

Classification of autism and related conditions: progress, challenges, and opportunities
por: Volkmar, Fred R., et al.
Publicado: (2012)

Pro- and anti-fibrotic effects of vascular endothelial growth factor in chronic kidney diseases
por: Miao, Changxiu, et al.
Publicado: (2022)

Targeting Vascular Calcification in Chronic Kidney Disease
por: Nelson, Adam J., et al.
Publicado: (2020)

Epidemiology of Alzheimer's disease: occurrence, determinants, and strategies toward intervention
por: Qiu, Chengxuan, et al.
Publicado: (2009)

Imaging Cancer Metabolism: Underlying Biology and Emerging Strategies
por: Pantel, Austin R., et al.
Publicado: (2018)

Expression profiling of drug response - from genes to pathways
por: Herwig, Ralf, et al.
Publicado: (2006)

Historical and cultural aspects of man's relationship with addictive drugs
por: Crocq, Marc-Antoine
Publicado: (2007)

Wasp venom-induced acute kidney injury: current progress and prospects
por: Yu, Fanglin, et al.
Publicado: (2023)

The research status and prospect of Periostin in chronic kidney disease
por: Jia, Yuan-yuan, et al.
Publicado: (2020)

Leveraging big data to transform target selection and drug discovery
por: Chen, B, et al.
Publicado: (2016)

Epidemiology and treatment of depression in patients with chronic medical illness
por: J. Katon, Wayne.
Publicado: (2011)

Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease
por: Halpin, David M. G., et al.
Publicado: (2021)

The role of kidney injury biomarkers in COVID-19
por: Su, Lianjiu, et al.
Publicado: (2022)

Acquired long QT syndrome in chronic kidney disease patients
por: Liu, Peng, et al.
Publicado: (2019)

Advances in oxidative stress in pathogenesis of diabetic kidney disease and efficacy of TCM intervention
por: Ma, Xiaoju, et al.
Publicado: (2023)

Gonadal steroids, brain, and behavior: role of context
por: Rubinow, David R., et al.
Publicado: (2002)

Metabolic Concepts in Idiopathic Intracranial Hypertension and Their Potential for Therapeutic Intervention
por: Hornby, Catherine, et al.
Publicado: (2018)

Protective and damaging effects of stress mediators: central role of the brain
por: McEwen, Bruce S.
Publicado: (2006)

Highlights of Pharmacist Roles in Hematopoietic Cell Transplantation and Cellular Therapy
por: Shi, Ho Ying, et al.
Publicado: (2021)

From adaptive licensing to adaptive pathways: Delivering a flexible life‐span approach to bring new drugs to patients
por: Eichler, H‐G, et al.
Publicado: (2015)

Iron metabolism and chronic inflammation in IgA nephropathy
por: Tian, Zhang-yu, et al.
Publicado: (2023)

Vascular Calcification in Chronic Kidney Disease: Distinct Features of Pathogenesis and Clinical Implication
por: Kim, Jin Sug, et al.
Publicado: (2021)

Estrogen and estrogen receptors in kidney diseases
por: Ma, Hao-Yang, et al.
Publicado: (2021)

Defining High Bleeding Risk in Patients Undergoing Percutaneous Coronary Intervention: A Consensus Document From the Academic Research Consortium for High Bleeding Risk
por: Urban, Philip, et al.
Publicado: (2019)

Mechanistic Model‐Informed Proarrhythmic Risk Assessment of Drugs: Review of the “CiPA” Initiative and Design of a Prospective Clinical Validation Study
por: Vicente, Jose, et al.
Publicado: (2017)

Functional maturation of nasal mucosa: role of secretory immunoglobulin A (SIgA)
por: Bellussi, Luisa, et al.
Publicado: (2013)

Solitary pulmonary nodule imaging approaches and the role of optical fibre-based technologies
por: Fernandes, Susan, et al.
Publicado: (2021)

Clinical roles of TIM-3 in myeloid malignancies and its importance in cellular therapy
por: Kikushige, Yoshikane
Publicado: (2022)

Subfractions of high-density lipoprotein (HDL) and dysfunctional HDL in chronic kidney disease patients
por: Rysz-Górzyńska, Magdalena, et al.
Publicado: (2016)

Review of the efficacy of AST-120 (KREMEZIN(®)) on renal function in chronic kidney disease patients
por: Asai, Mayumi, et al.
Publicado: (2019)

Specific alterations in gut microbiota in patients with chronic kidney disease: an updated systematic review
por: Zhao, Jin, et al.
Publicado: (2021)

Targeting BCL2 With BH3 Mimetics: Basic Science and Clinical Application of Venetoclax in Chronic Lymphocytic Leukemia and Related B Cell Malignancies
por: Roberts, AW, et al.
Publicado: (2016)

Calcitriol, calcidiol, parathyroid hormone, and fibroblast growth factor-23 interactions in chronic kidney disease
por: Brito Galvao, Joao F, et al.
Publicado: (2013)

Role of extracellular vesicles in chronic lung disease
por: Trappe, Anne, et al.
Publicado: (2021)

Metabolic dysfunction and inflammatory disease: the role of stromal fibroblasts
por: Farah, Hussein, et al.
Publicado: (2020)

Critical Analysis of the Effects of SGLT2 Inhibitors on Renal Tubular Sodium, Water and Chloride Homeostasis and Their Role in Influencing Heart Failure Outcomes
por: Packer, Milton, et al.
Publicado: (2023)

A systemic review and meta-analysis on the efficacy and safety of ferumoxytol for anemia in chronic kidney disease patients
por: Zuo, Qianwei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ldueq8hhrpm1ha5th59b5ub16h